232 related articles for article (PubMed ID: 34789768)
21. The BRCA1/BARD1 ubiquitin ligase and its substrates.
Witus SR; Stewart MD; Klevit RE
Biochem J; 2021 Sep; 478(18):3467-3483. PubMed ID: 34591954
[TBL] [Abstract][Full Text] [Related]
22. Structural insight into BRCA1-BARD1 complex recruitment to damaged chromatin.
Dai L; Dai Y; Han J; Huang Y; Wang L; Huang J; Zhou Z
Mol Cell; 2021 Jul; 81(13):2765-2777.e6. PubMed ID: 34102105
[TBL] [Abstract][Full Text] [Related]
23. Estrogen receptor alpha is a putative substrate for the BRCA1 ubiquitin ligase.
Eakin CM; Maccoss MJ; Finney GL; Klevit RE
Proc Natl Acad Sci U S A; 2007 Apr; 104(14):5794-9. PubMed ID: 17392432
[TBL] [Abstract][Full Text] [Related]
24. CRL4-DCAF8L1 Regulates BRCA1 and BARD1 Protein Stability.
Liu F; Han Q; Zhang T; Chang F; Deng J; Huang X; Wang W; Xu Y; Li Q; Xu L; Zhang B; Li W; Li L; Su Y; Li Y; Shao G
Int J Biol Sci; 2022; 18(4):1434-1450. PubMed ID: 35280675
[TBL] [Abstract][Full Text] [Related]
25. BRCA1/BARD1 site-specific ubiquitylation of nucleosomal H2A is directed by BARD1.
Witus SR; Burrell AL; Farrell DP; Kang J; Wang M; Hansen JM; Pravat A; Tuttle LM; Stewart MD; Brzovic PS; Chatterjee C; Zhao W; DiMaio F; Kollman JM; Klevit RE
Nat Struct Mol Biol; 2021 Mar; 28(3):268-277. PubMed ID: 33589814
[TBL] [Abstract][Full Text] [Related]
26. Human BRCA1-BARD1 ubiquitin ligase activity counteracts chromatin barriers to DNA resection.
Densham RM; Garvin AJ; Stone HR; Strachan J; Baldock RA; Daza-Martin M; Fletcher A; Blair-Reid S; Beesley J; Johal B; Pearl LH; Neely R; Keep NH; Watts FZ; Morris JR
Nat Struct Mol Biol; 2016 Jul; 23(7):647-55. PubMed ID: 27239795
[TBL] [Abstract][Full Text] [Related]
27. Dysregulation of the centrosome induced by BRCA1 deficiency contributes to tissue-specific carcinogenesis.
Yoshino Y; Fang Z; Qi H; Kobayashi A; Chiba N
Cancer Sci; 2021 May; 112(5):1679-1687. PubMed ID: 33606355
[TBL] [Abstract][Full Text] [Related]
28. Specific killing of DNA damage-response deficient cells with inhibitors of poly(ADP-ribose) glycohydrolase.
Gravells P; Grant E; Smith KM; James DI; Bryant HE
DNA Repair (Amst); 2017 Apr; 52():81-91. PubMed ID: 28254358
[TBL] [Abstract][Full Text] [Related]
29. RNF168-mediated localization of BARD1 recruits the BRCA1-PALB2 complex to DNA damage.
Krais JJ; Wang Y; Patel P; Basu J; Bernhardy AJ; Johnson N
Nat Commun; 2021 Aug; 12(1):5016. PubMed ID: 34408138
[TBL] [Abstract][Full Text] [Related]
30. L ARP7 Is a BRCA1 Ubiquitinase Substrate and Regulates Genome Stability and Tumorigenesis.
Zhang F; Yan P; Yu H; Le H; Li Z; Chen J; Liang X; Wang S; Wei W; Liu L; Zhang Y; Ji X; Xie A; Chen W; Han Z; Pu WT; Chen S; Chen Y; Sun K; Ge B; Zhang B
Cell Rep; 2020 Jul; 32(4):107974. PubMed ID: 32726637
[TBL] [Abstract][Full Text] [Related]
31. Differences in Expression of Key DNA Damage Repair Genes after Epigenetic-Induced BRCAness Dictate Synthetic Lethality with PARP1 Inhibition.
Wiegmans AP; Yap PY; Ward A; Lim YC; Khanna KK
Mol Cancer Ther; 2015 Oct; 14(10):2321-31. PubMed ID: 26294743
[TBL] [Abstract][Full Text] [Related]
32. Nuclear-cytoplasmic shuttling of BARD1 contributes to its proapoptotic activity and is regulated by dimerization with BRCA1.
Rodriguez JA; Schüchner S; Au WW; Fabbro M; Henderson BR
Oncogene; 2004 Mar; 23(10):1809-20. PubMed ID: 14647430
[TBL] [Abstract][Full Text] [Related]
33. Characterization of BARD1 targeting and dynamics at the centrosome: the role of CRM1, BRCA1 and the Q564H mutation.
Brodie KM; Mok MTS; Henderson BR
Cell Signal; 2012 Feb; 24(2):451-459. PubMed ID: 21982881
[TBL] [Abstract][Full Text] [Related]
34. BRCA1/BARD1 is a nucleosome reader and writer.
Witus SR; Zhao W; Brzovic PS; Klevit RE
Trends Biochem Sci; 2022 Jul; 47(7):582-595. PubMed ID: 35351360
[TBL] [Abstract][Full Text] [Related]
35. Molecular dynamics simulations reveal the effect of mutations in the RING domains of BRCA1-BARD1 complex and its relevance to the prognosis of breast cancer.
Kiewhuo K; Priyadarsinee L; Sarma H; Sastry GN
J Biomol Struct Dyn; 2023; 41(22):12734-12752. PubMed ID: 36775657
[TBL] [Abstract][Full Text] [Related]
36. BRCA1 and BARD1 colocalize mainly in the cytoplasm of breast cancer tumors, and their isoforms show differential expression.
Wiener D; Gajardo-Meneses P; Ortega-Hernández V; Herrera-Cares C; Díaz S; Fernández W; Cornejo V; Gamboa J; Tapia T; Alvarez C; Carvallo P
Breast Cancer Res Treat; 2015 Oct; 153(3):669-78. PubMed ID: 26395808
[TBL] [Abstract][Full Text] [Related]
37. The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation.
Hashizume R; Fukuda M; Maeda I; Nishikawa H; Oyake D; Yabuki Y; Ogata H; Ohta T
J Biol Chem; 2001 May; 276(18):14537-40. PubMed ID: 11278247
[TBL] [Abstract][Full Text] [Related]
38. In silico investigation on the mutational analysis of BRCA1-BARD1 RING domains and its effect on nucleosome recognition and ubiquitination.
Sarma H; Kiewhuo K; Jamir E; Sastry GN
Biophys Chem; 2023 Sep; 300():107070. PubMed ID: 37339533
[TBL] [Abstract][Full Text] [Related]
39. Computational structural assessment of BReast CAncer type 1 susceptibility protein (BRCA1) and BRCA1-Associated Ring Domain protein 1 (BARD1) mutations on the protein-protein interface.
Thirumal Kumar D; Udhaya Kumar S; Jain N; Sowmya B; Balsekar K; Siva R; Kamaraj B; Sidenna M; George Priya Doss C; Zayed H
Adv Protein Chem Struct Biol; 2022; 130():375-397. PubMed ID: 35534113
[TBL] [Abstract][Full Text] [Related]
40. BRCA1-associated protein 1 interferes with BRCA1/BARD1 RING heterodimer activity.
Nishikawa H; Wu W; Koike A; Kojima R; Gomi H; Fukuda M; Ohta T
Cancer Res; 2009 Jan; 69(1):111-9. PubMed ID: 19117993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
